Dimensional Fund Advisors LP Bridge Bio Pharma, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 62,701 shares of BBIO stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,701

Previous 73,230 14.38%

Holding current value

$1.66 Million

Previous $1.85 Million 13.92%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$23.91 - $31.3 $251,748 - $329,557	-10,529 Reduced 14.38%	62,701 $1.6 Million
Q2 2024 Aug 09, 2024	BUY	$23.0 - $31.04 $83,352 - $112,488	3,624 Added 5.21%	73,230 $1.85 Million
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $601,070 - $888,969	21,977 Added 46.14%	69,606 $2.15 Million
Q4 2023 Feb 07, 2024	BUY	$24.02 - $43.89 $53,660 - $98,050	2,234 Added 4.92%	47,629 $1.92 Million
Q3 2023 Nov 09, 2023	BUY	$16.89 - $35.01 $766,721 - $1.59 Million	45,395 New	45,395 $1.2 Million
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $230,967 - $539,973	-31,467 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$11.38 - $53.41 $1.76 Million - $8.28 Million	-154,971 Reduced 83.12%	31,467 $525,000
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $1.72 Million - $2.36 Million	36,789 Added 24.58%	186,438 $8.74 Million
Q2 2021 Aug 12, 2021	BUY	$46.47 - $63.93 $3.21 Million - $4.42 Million	69,143 Added 85.89%	149,649 $9.12 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $2.65 Million - $3.46 Million	47,835 Added 146.41%	80,506 $4.96 Million
Q4 2020 Feb 25, 2021	BUY	$38.38 - $71.11 $1.25 Million - $2.32 Million	32,671 New	32,671 $2.32 Million

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.93B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Bridge Bio Pharma, Inc. Transaction History